ICU Medical Inc
NASDAQ:ICUI

Watchlist Manager
ICU Medical Inc Logo
ICU Medical Inc
NASDAQ:ICUI
Watchlist
Price: 168.46 USD -0.23% Market Closed
Market Cap: 4.1B USD
Have any thoughts about
ICU Medical Inc?
Write Note

Intrinsic Value

The intrinsic value of one ICUI stock under the Base Case scenario is 190.76 USD. Compared to the current market price of 168.46 USD, ICU Medical Inc is Undervalued by 12%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ICUI Intrinsic Value
190.76 USD
Undervaluation 12%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
ICU Medical Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ICUI cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ICUI?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about ICU Medical Inc

Provide an overview of the primary business activities
of ICU Medical Inc.

What unique competitive advantages
does ICU Medical Inc hold over its rivals?

What risks and challenges
does ICU Medical Inc face in the near future?

Has there been any significant insider trading activity
in ICU Medical Inc recently?

Summarize the latest earnings call
of ICU Medical Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for ICU Medical Inc.

Provide P/S
for ICU Medical Inc.

Provide P/E
for ICU Medical Inc.

Provide P/OCF
for ICU Medical Inc.

Provide P/FCFE
for ICU Medical Inc.

Provide P/B
for ICU Medical Inc.

Provide EV/S
for ICU Medical Inc.

Provide EV/GP
for ICU Medical Inc.

Provide EV/EBITDA
for ICU Medical Inc.

Provide EV/EBIT
for ICU Medical Inc.

Provide EV/OCF
for ICU Medical Inc.

Provide EV/FCFF
for ICU Medical Inc.

Provide EV/IC
for ICU Medical Inc.

Show me price targets
for ICU Medical Inc made by professional analysts.

What are the Revenue projections
for ICU Medical Inc?

How accurate were the past Revenue estimates
for ICU Medical Inc?

What are the Net Income projections
for ICU Medical Inc?

How accurate were the past Net Income estimates
for ICU Medical Inc?

What are the EPS projections
for ICU Medical Inc?

How accurate were the past EPS estimates
for ICU Medical Inc?

What are the EBIT projections
for ICU Medical Inc?

How accurate were the past EBIT estimates
for ICU Medical Inc?

Compare the revenue forecasts
for ICU Medical Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of ICU Medical Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of ICU Medical Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of ICU Medical Inc compared to its peers.

Compare the P/E ratios
of ICU Medical Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing ICU Medical Inc with its peers.

Analyze the financial leverage
of ICU Medical Inc compared to its main competitors.

Show all profitability ratios
for ICU Medical Inc.

Provide ROE
for ICU Medical Inc.

Provide ROA
for ICU Medical Inc.

Provide ROIC
for ICU Medical Inc.

Provide ROCE
for ICU Medical Inc.

Provide Gross Margin
for ICU Medical Inc.

Provide Operating Margin
for ICU Medical Inc.

Provide Net Margin
for ICU Medical Inc.

Provide FCF Margin
for ICU Medical Inc.

Show all solvency ratios
for ICU Medical Inc.

Provide D/E Ratio
for ICU Medical Inc.

Provide D/A Ratio
for ICU Medical Inc.

Provide Interest Coverage Ratio
for ICU Medical Inc.

Provide Altman Z-Score Ratio
for ICU Medical Inc.

Provide Quick Ratio
for ICU Medical Inc.

Provide Current Ratio
for ICU Medical Inc.

Provide Cash Ratio
for ICU Medical Inc.

What is the historical Revenue growth
over the last 5 years for ICU Medical Inc?

What is the historical Net Income growth
over the last 5 years for ICU Medical Inc?

What is the current Free Cash Flow
of ICU Medical Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for ICU Medical Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
ICU Medical Inc

Current Assets 1.3B
Cash & Short-Term Investments 312.5m
Receivables 177.7m
Other Current Assets 767.8m
Non-Current Assets 3B
Long-Term Investments 3.1m
PP&E 658.5m
Intangibles 2.3B
Other Non-Current Assets 121.3m
Current Liabilities 549.6m
Accounts Payable 168.6m
Accrued Liabilities 297.8m
Other Current Liabilities 83.2m
Non-Current Liabilities 1.7B
Long-Term Debt 1.5B
Other Non-Current Liabilities 161.3m
Efficiency

Earnings Waterfall
ICU Medical Inc

Revenue
2.3B USD
Cost of Revenue
-1.6B USD
Gross Profit
769.1m USD
Operating Expenses
-715.2m USD
Operating Income
53.9m USD
Other Expenses
-164.9m USD
Net Income
-111m USD

Free Cash Flow Analysis
ICU Medical Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In Q3 2024, ICU Medical reported revenues of $580 million, reflecting a 7% increase year-over-year. The company achieved an adjusted EBITDA of $95 million and an EPS of $1.59. Notably, it experienced improved gross margins due to operational efficiencies, expected to maintain between 36-37% in Q4. ICU Medical anticipates full-year adjusted EBITDA between $355 million and $365 million, revising EPS guidance to $5.40-$5.70 per share. A significant joint venture with Otsuka Pharmaceutical aims to enhance IV Solutions, expected to improve operational efficiency and market position, although ICU will deconsolidate related revenue and recognize proportional net earnings.

What is Earnings Call?
Fundamental Scores

ICUI Profitability Score
Profitability Due Diligence

ICU Medical Inc's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Positive Free Cash Flow
Positive Revenue Growth Forecast
44/100
Profitability
Score

ICU Medical Inc's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

ICUI Solvency Score
Solvency Due Diligence

ICU Medical Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Average Altman Z-Score
51/100
Solvency
Score

ICU Medical Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ICUI Price Targets Summary
ICU Medical Inc

Wall Street analysts forecast ICUI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ICUI is 212.77 USD with a low forecast of 202 USD and a high forecast of 236.25 USD.

Lowest
Price Target
202 USD
20% Upside
Average
Price Target
212.77 USD
26% Upside
Highest
Price Target
236.25 USD
40% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ICUI?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for ICUI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ICUI Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

ICU Medical Inc Logo
ICU Medical Inc

Country

United States of America

Industry

Health Care

Market Cap

4.1B USD

Dividend Yield

0%

Description

ICU Medical, Inc. engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. The company is headquartered in San Clemente, California and currently employs 8,500 full-time employees. The firm provides infusion systems, infusion consumables and critical care products used in hospital, alternate site and home care settings. The firm's product portfolio includes IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle free connectors. Its oncology products include ChemoLock and ChemoClave. Its IV consumables include Clave IV Connector Technology, IV Sets, Peripheral IV Catheters and Disinfecting Caps. Its primary critical care products include Cogent, CardioFlo, TDQ and OptiQ, TriOx, Transpac and SafeSet. Its IV Solutions products include IV Therapy and Diluents, and Irrigation. Its Infusion System products include Infusion Pump Hardware, IV Mediation Safety Software and Professional Services. The company offers blood pressure monitoring system.

Contact

CALIFORNIA
San Clemente
951 Calle Amanecer
+19493662183.0
www.icumed.com

IPO

1992-03-31

Employees

8 500

Officers

CEO & Chairman of the Board
Mr. Vivek Jain
President
Mr. Daniel Woolson
CFO & Treasurer
Mr. Brian Michael Bonnell
Chief Operating Officer
Mr. Christian B. Voigtlander
Corporate VP, General Counsel, Secretary & Compliance Officer
Ms. Virginia Ruth Sanzone

See Also

Discover More
What is the Intrinsic Value of one ICUI stock?

The intrinsic value of one ICUI stock under the Base Case scenario is 190.76 USD.

Is ICUI stock undervalued or overvalued?

Compared to the current market price of 168.46 USD, ICU Medical Inc is Undervalued by 12%.

Back to Top